RAFA LABORATORIES LTD: $33.4M Department of Health and Human Services Contract
Summary
This $33.4M contract to private RAFA LABORATORIES LTD for atropine auto-injectors supports the Strategic National Stockpile but does not directly benefit any publicly traded company. The award reinforces biodefense preparedness spending, a steady but niche healthcare sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No publicly traded company directly benefits from this contract.
- 2.The award is a routine stockpile replenishment with limited market impact.
- 3.Biodefense spending remains a steady but small healthcare niche.
Market Implications
This contract has negligible direct market implications as the recipient is private. The broader biodefense sector remains stable but unexciting for public equity investors, with no tickers to trade on this news.
Full Analysis
The Department of Health and Human Services awarded RAFA LABORATORIES LTD a $33.4M definitive contract for atropine auto-injectors (0.5 mg, 1 mg, and 2 mg) to replenish the Strategic National Stockpile for nerve agent and organophosphate poisoning treatment. RAFA LABORATORIES LTD is a private Israeli firm, so no public company directly receives this revenue. The contract spans 2025-2027, indicating multi-year stockpile maintenance. No related legislation directly authorizes this specific award, though broader biodefense bills like the SERVE Act (HR9822) and AI-Ready Bio-Data Standards Act (S4069) signal continued government interest in healthcare preparedness. Supply chain beneficiaries are speculative and not identifiable from public data. Historically, stockpile contracts are routine and low-impact for public markets, as they involve niche private manufacturers.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
RAFA LABORATORIES LTD
Award Amount
$33,392,937
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →